Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor

BACKGROUND: As the COVID-19 pandemic rages on, the new SARS-CoV-2 variants have emerged in the different regions of the world. These newly emerged variants have mutations in their spike (S) protein that may confer resistance to vaccine-elicited immunity and existing neutralizing antibody therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinbiao, Bodnar, Brittany H., Meng, Fengzhen, Khan, Adil I., Wang, Xu, Saribas, Sami, Wang, Tao, Lohani, Saroj Chandra, Wang, Peng, Wei, Zhengyu, Luo, Jinjun, Zhou, Lina, Wu, Jianguo, Luo, Guangxiang, Li, Qingsheng, Hu, Wenhui, Ho, Wenzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404181/
https://www.ncbi.nlm.nih.gov/pubmed/34461999
http://dx.doi.org/10.1186/s13578-021-00680-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404181/
https://www.ncbi.nlm.nih.gov/pubmed/34461999
http://dx.doi.org/10.1186/s13578-021-00680-8

Ejemplares similares